Holen Sie sich die Stockscreener-App
1.29
3.73%
-0.05
Tevogen Bio Holdings Inc Aktie (TVGN) Neueste Nachrichten
Tevogen Bio expands AI in immunotherapy development By Investing.com - Investing.com South Africa
Tevogen Bio Holdings Inc. Unveils Tevogen.AI™ Initiative to Enhance Immunotherapy Development with Advanced AI Technologies - Nasdaq
Tevogen Details its Artificial Intelligence Initiative, - GlobeNewswire
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered ... - Bluefield Daily Telegraph
Tevogen Teams Up with Microsoft to Transform Healthcare: New AI Platform Targets $5T Industry - Stock Titan
Tariff Twist and PCE Ahead—Markets Hold Key Support - The Globe and Mail
This Raytheon Rival Is on Track to Hit New 52-Week Highs - The Globe and Mail
PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla - The Globe and Mail
Is IonQ Stock a Buy Now? - The Globe and Mail
Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Sees Large Drop in Short Interest - Defense World
Tevogen Bio (NASDAQ:TVGN) Given Buy Rating at D. Boral Capital - Defense World
4 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - The Globe and Mail
Tevogen Peports Plans to Increase the Target Population for TVGN 489 - Insider Monkey
Tevogen expands target for COVID treatment to seniors - Investing.com Australia
Tevogen expands target for COVID treatment to seniors By Investing.com - Investing.com Nigeria
Tevogen Bio Plans to Expand Specialty Care Pipeline to - GlobeNewswire
Tevogen to Update on Robust Portfolio Assets, Business - GlobeNewswire
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited Tradable Float, High Insider Ownership and Strong Investor Confidence Ahead of June 23 Annual Meeting - The Manila Times
Tevogen Bio Holdings Inc. to Provide Key Updates Ahead of Annual Meeting on June 23, 2025 - Nasdaq
Tevogen to Update on Robust Portfolio Assets, Business Expansion, Partnerships, Limited ... - Bluefield Daily Telegraph
Tevogen Unveils Massive $10B Portfolio Valuation and AI Expansion Ahead of Critical June Meeting - Stock Titan
Nvidia-Foxconn AI Alliance Could Disrupt the Supercomputer Market—What’s at Stake for Investors - The Globe and Mail
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Stock Position Raised by Barclays PLC - Defense World
Tevogen Bio Holdings Inc. SEC 10-Q Report - TradingView
Tevogen Bio (NASDAQ:TVGN) Given “Buy” Rating at D. Boral Capital - Defense World
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - The Manila Times
Tevogen Bio Positions Itself as a Leader in Cost-Efficient Healthcare Amid Global Pharmaceutical Competition - Nasdaq
JPMorgan Chase & Co. Has $40,000 Stake in Tevogen Bio Holdings Inc. (NASDAQ:TVGN) - Defense World
Tevogen Bio's First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned - ADVFN
AI Healthcare Boom Gains Speed as Regulators and Innovators Align - The Globe and Mail
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Shares Acquired by Geode Capital Management LLC - Defense World
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest - The Manila Times
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased ... - Bluefield Daily Telegraph
Tevogen Major Shareholders Choose DRS: Company to Release Step-by-Step Registration Guide Next Week - Stock Titan
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
CD8 Technology Signs Letter of Intent for Tevogen Bio's In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment - The Manila Times
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, ... - Bluefield Daily Telegraph
CD8 Technology Signs Letter of Intent for Tevogen Bio’s - GlobeNewswire
Tevogen Bio's $50M Manufacturing Expansion Backed by 74% Insider Ownership - Stock Titan
Tevogen sees launch year oncology business revenue $1B - Yahoo Finance
Tevogen highlights DRS account benefits for shareholders By Investing.com - Investing.com India
Tevogen Bio shares surge on revenue forecast By Investing.com - Investing.com Nigeria
Tevogen Bio shares surge on revenue forecast - Investing.com
Tevogen highlights DRS account benefits for shareholders - Investing.com
Direct Registration vs Brokerage: Tevogen Reveals Key Benefits for Shareholders - Stock Titan
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ's Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald - The Manila Times
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald - GlobeNewswire
Tevogen CEO Teams with Wall Street Giants to Navigate Biotech Market Volatility at BioNJ Conference - Stock Titan
Why Leggett & Platt Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Tevogen CEO To Join Dialogue On Paths To Liquidity at BioNJ's Fifteenth Annual Bio Partnering Conference - marketscreener.com
Tevogen shares skyrocket as it projects $1B in revenue for its oncology pipeline - MSN
Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On? - Benzinga
Tevogen Bio Holdings Inc. Secures $50 Million Agreement with CD8 Technology Services to Enhance R&D and Manufacturing Capabilities - Nasdaq
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and ... - Eagle-Tribune
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 - GlobeNewswire
Tevogen's Revolutionary Cancer Drug Pipeline Could Generate $14 Billion: Inside the Forecast - Stock Titan
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):